134 related articles for article (PubMed ID: 12161039)
1. Reduced expression of the inhibitor of apoptosis proteins in T cells from patients with multiple sclerosis following interferon-beta therapy.
Sharief MK; Noori MA; Zoukos Y
J Neuroimmunol; 2002 Aug; 129(1-2):224-31. PubMed ID: 12161039
[TBL] [Abstract][Full Text] [Related]
2. Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis.
Sharief MK; Semra YK; Seidi OA; Zoukos Y
J Neuroimmunol; 2001 Nov; 120(1-2):199-207. PubMed ID: 11694335
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis.
Sharief MK; Semra YK
Arch Neurol; 2002 Jul; 59(7):1115-21. PubMed ID: 12117359
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis.
Sharief MK; Semra YK
J Neuroimmunol; 2001 Oct; 119(2):350-7. PubMed ID: 11585639
[TBL] [Abstract][Full Text] [Related]
5. Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins.
Semra YK; Seidi OA; Sharief MK
J Neuroimmunol; 2002 Jan; 122(1-2):159-66. PubMed ID: 11777555
[TBL] [Abstract][Full Text] [Related]
6. Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis.
Sharief MK; Noori MA; Douglas MR; Semra YK
Eur J Neurol; 2002 Sep; 9(5):503-10. PubMed ID: 12220382
[TBL] [Abstract][Full Text] [Related]
7. Expression ratios of the Bcl-2 family proteins and disease activity in multiple sclerosis.
Sharief MK; Matthews H; Noori MA
J Neuroimmunol; 2003 Jan; 134(1-2):158-65. PubMed ID: 12507784
[TBL] [Abstract][Full Text] [Related]
8. The expression of apoptosis-regulatory proteins in B lymphocytes from patients with multiple sclerosis.
Seidi OA; Sharief MK
J Neuroimmunol; 2002 Sep; 130(1-2):202-10. PubMed ID: 12225903
[TBL] [Abstract][Full Text] [Related]
9. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis.
Sharief MK; Douglas M; Noori M; Semra YK
J Neuroimmunol; 2002 Apr; 125(1-2):155-62. PubMed ID: 11960652
[TBL] [Abstract][Full Text] [Related]
10. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination.
Hebb AL; Moore CS; Bhan V; Campbell T; Fisk JD; Robertson HA; Thorne M; Lacasse E; Holcik M; Gillard J; Crocker SJ; Robertson GS
Mult Scler; 2008 Jun; 14(5):577-94. PubMed ID: 18566024
[TBL] [Abstract][Full Text] [Related]
11. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.
Feng X; Petraglia AL; Chen M; Byskosh PV; Boos MD; Reder AT
J Neuroimmunol; 2002 Aug; 129(1-2):205-15. PubMed ID: 12161037
[TBL] [Abstract][Full Text] [Related]
12. Targeting apoptosis to treat multiple sclerosis.
Hebb AL; Moore CS; Bhan V; Robertson GS
Curr Drug Discov Technol; 2008 Mar; 5(1):75-7. PubMed ID: 18537570
[TBL] [Abstract][Full Text] [Related]
13. Fas aggregation does not correlate with Fas-mediated apoptosis.
Lee Y; Shacter E
J Immunol; 2001 Jul; 167(1):82-9. PubMed ID: 11418635
[TBL] [Abstract][Full Text] [Related]
14. Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis.
Küenzi P; Schneider P; Dobbelaere DA
J Immunol; 2003 Aug; 171(3):1224-31. PubMed ID: 12874209
[TBL] [Abstract][Full Text] [Related]
15. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
[TBL] [Abstract][Full Text] [Related]
16. β-elemene induces caspase-dependent apoptosis in human glioma cells in vitro through the upregulation of Bax and Fas/ FasL and downregulation of Bcl-2.
Li CL; Chang L; Guo L; Zhao D; Liu HB; Wang QS; Zhang P; Du WZ; Liu X; Zhang HT; Liu Y; Zhang Y; Xie JH; Ming JG; Cui YQ; Sun Y; Zhang ZR; Jiang CL
Asian Pac J Cancer Prev; 2014; 15(23):10407-12. PubMed ID: 25556484
[TBL] [Abstract][Full Text] [Related]
17. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
18. Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.
Rizzo F; Giacomini E; Mechelli R; Buscarinu MC; Salvetti M; Severa M; Coccia EM
Immunol Cell Biol; 2016 Oct; 94(9):886-894. PubMed ID: 27265253
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis.
Semra YK; Seidi OA; Sharief MK
J Neuroimmunol; 2001 Feb; 113(2):268-74. PubMed ID: 11164911
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection.
Boudet F; Lecoeur H; Gougeon ML
J Immunol; 1996 Mar; 156(6):2282-93. PubMed ID: 8690919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
